Mycoplasma/Ureaplasma infection in pregnancy: to screen or not to screen

References

[1] Lee SE, Romero R, Kim EC, Yoon BH. A high Nugent score but not a positive culture for genital mycoplasmas is a risk factor for spontaneous preterm birth. J Matern Fetal Neonatal Med. 2009;22:212–7.10.1080/14767050802616994Search in Google Scholar PubMed PubMed Central

[2] Smith DG, Russell WC, Thirkell D. Adherence of Ureaplasma urealyticum to human epithelial cells. Microbiology. 1994;140(Pt 10):2893–8.10.1099/00221287-140-10-2893Search in Google Scholar PubMed

[3] Christiansen G, Jensen LT, Boesen T, Emmersen J, Ladefoged SA, Schiotz LK, et al. Molecular biology of Mycoplasma. Wien Klin Wochenschr. 1997;109:557–61.Search in Google Scholar

[4] Harada K, Tanaka H, Komori S, Tsuji Y, Nagata K, Tsutsui H, et al. Vaginal infection with Ureaplasma urealyticum accounts for preterm delivery via induction of inflammatory responses. Microbiol Immunol. 2008;52:297–304.10.1111/j.1348-0421.2008.00039.xSearch in Google Scholar PubMed

[5] Donders GG, Van CK, Bellen G, Reybrouck R, Van den Bosch T, Riphagen I, et al. Predictive value for preterm birth of abnormal vaginal flora, bacterial vaginosis and aerobic vaginitis during the first trimester of pregnancy. Br J Obstet Gynaecol. 2009;116:1315–24.10.1111/j.1471-0528.2009.02237.xSearch in Google Scholar PubMed

[6] Rezeberga D, Lazdane G, Kroica J, Sokolova L, Donders GG. Placental histological inflammation and reproductive tract infections in a low risk pregnant population in Latvia. Acta Obstet Gynecol Scand. 2008;87:360–5.10.1080/00016340801936487Search in Google Scholar PubMed

[7] Cunningham CK, Bonville CA, Hagen JH, Belkowitz JL, Kawatu RM, Higgins AM, et al. Immunoblot analysis of anti-Ureaplasma urealyticum antibody in pregnant women and newborn infants. Clin Diagn Lab Immunol. 1996;3:487–92.10.1128/cdli.3.5.487-492.1996Search in Google Scholar PubMed PubMed Central

[8] Ruzman N, Miskulin M, Rudan S, Bosnjak Z. The prevalence and the risk factors of the cervical colonization by the genital mycoplasmas among pregnant women from Eastern Croatia. Coll Antropol. 2013;37:135–40.Search in Google Scholar

[9] Faye-Kette H, La RG, Ali-Napo L, Messou N, Viho I, Welffens-Ekra C, et al. Genital mycoplasmas among pregnant women in Cote d’Ivoire, West Africa: prevalence and risk factors. Int J STD AIDS. 2000;11:599–602.10.1258/0956462001916452Search in Google Scholar PubMed

[10] Agbakoba NR, Adetosoye AI, Adewole IF. Presence of mycoplasma and ureaplasma species in the vagina of women of reproductive age. West Afr J Med. 2007;26:28–31.10.4314/wajm.v26i1.28299Search in Google Scholar PubMed

[11] Baczynska A, Hvid M, Lamy P, Birkelund S, Christiansen G, Fedder J. Prevalence of Mycoplasma genitalium, Mycoplasma hominis and Chlamydia trachomatis among Danish patients requesting abortion. Syst Biol Reprod Med. 2008;54:127–34.10.1080/19396360802042838Search in Google Scholar PubMed

[12] Averbach SH, Hacker MR, Yiu T, Modest AM, Dimitrakoff J, Ricciotti HA. Mycoplasma genitalium and preterm delivery at an urban community health center. Int J Gynaecol Obstet. 2013;123:54–7.10.1016/j.ijgo.2013.06.005Search in Google Scholar PubMed PubMed Central

[13] Bayraktar MR, Ozerol IH, Gucluer N, Celik O. Prevalence and antibiotic susceptibility of Mycoplasma hominis and Ureaplasma urealyticum in pregnant women. Int J Infect Dis. 2010;14:e90–5.10.1016/j.ijid.2009.03.020Search in Google Scholar PubMed

[14] Choi SJ, Park SD, Jang IH, Uh Y, Lee A. The prevalence of vaginal microorganisms in pregnant women with preterm labor and preterm birth. Ann Lab Med. 2012;32:194–200.10.3343/alm.2012.32.3.194Search in Google Scholar PubMed PubMed Central

[15] Lawton BA, Rose SB, Bromhead C, Gaitanos LA, MacDonald EJ, Lund KA. High prevalence of Mycoplasma genitalium in women presenting for termination of pregnancy. Contraception. 2008;77:294–8.10.1016/j.contraception.2007.12.002Search in Google Scholar PubMed

[16] Peuchant O, Le RC, Desveaux C, Paris A, Asselineau J, Maldonado C, et al. Screening for Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma genitalium should it be integrated into routine pregnancy care in French young pregnant women? Diagn Microbiol Infect Dis. 2015;82:14–9.10.1016/j.diagmicrobio.2015.01.014Search in Google Scholar PubMed

[17] Kataoka S, Yamada T, Chou K, Nishida R, Morikawa M, Minami M, et al. Association between preterm birth and vaginal colonization by mycoplasmas in early pregnancy. J Clin Microbiol. 2006;44:51–5.10.1128/JCM.44.1.51-55.2006Search in Google Scholar PubMed PubMed Central

[18] Labbe AC, Frost E, Deslandes S, Mendonca AP, Alves AC, Pepin J. Mycoplasma genitalium is not associated with adverse outcomes of pregnancy in Guinea-Bissau. Sex Transm Infect. 2002;78:289–91.10.1136/sti.78.4.289Search in Google Scholar PubMed PubMed Central

[19] Oakeshott P, Hay P, Taylor-Robinson D, Hay S, Dohn B, Kerry S, et al. Prevalence of Mycoplasma genitalium in early pregnancy and relationship between its presence and pregnancy outcome. Br J Obstet Gynaecol. 2004;111:1464–7.10.1111/j.1471-0528.2004.00276.xSearch in Google Scholar PubMed

[20] Jobe KA, Downey RF, Hammar D, Van SL, Schmidt TA. Epidemiology of sexually transmitted infections in rural southwestern Haiti: the Grand’Anse Women’s Health Study. Am J Trop Med Hyg. 2014;91:881–6.10.4269/ajtmh.13-0762Search in Google Scholar PubMed PubMed Central

[21] Zheng BJ, Yin YP, Xiang Z, Han Y, Shi MQ, Jiang N, et al. An epidemiological study of Mycoplasma genitalium infections among males attending a sexually transmitted disease clinic in Guangxi, China. Jpn J Infect Dis. 2014;67:17–21.10.7883/yoken.67.17Search in Google Scholar PubMed

[22] Gesink DC, Mulvad G, Montgomery-Andersen R, Poppel U, Montgomery-Andersen S, Binzer A, et al. Mycoplasma genitalium presence, resistance and epidemiology in Greenland. Int J Circumpolar Health. 2012;71:1–8.10.3402/ijch.v71i0.18203Search in Google Scholar PubMed PubMed Central

[23] Shipitsyna E, Krasnoselskikh T, Zolotoverkhaya E, Savicheva A, Krotin P, Domeika M, et al. Sexual behaviours, knowledge and attitudes regarding safe sex, and prevalence of non-viral sexually transmitted infections among attendees of youth clinics in St. Petersburg, Russia. J Eur Acad Dermatol Venereol. 2013;27:e75–84.10.1111/j.1468-3083.2012.04512.xSearch in Google Scholar

[24] Manhart LE, Critchlow CW, Holmes KK, Dutro SM, Eschenbach DA, Stevens CE, et al. Mucopurulent cervicitis and Mycoplasma genitalium. J Infect Dis. 2003;187:650–7.10.1086/367992Search in Google Scholar

[25] Jacobsson B, Mattsby-Baltzer I, Andersch B, Bokstrom H, Holst RM, Nikolaitchouk N, et al. Microbial invasion and cytokine response in amniotic fluid in a Swedish population of women with preterm prelabor rupture of membranes. Acta Obstet Gynecol Scand. 2003;82:423–31.10.1034/j.1600-0412.2003.00157.xSearch in Google Scholar

[26] Bujold E, Morency AM, Rallu F, Ferland S, Tetu A, Duperron L, et al. Bacteriology of amniotic fluid in women with suspected cervical insufficiency. J Obstet Gynaecol Can. 2008;30:882–7.10.1016/S1701-2163(16)32967-XSearch in Google Scholar

[27] Oh KJ, Lee SE, Jung H, Kim G, Romero R, Yoon BH. Detection of ureaplasmas by the polymerase chain reaction in the amniotic fluid of patients with cervical insufficiency. J Perinat Med. 2010;38:261–8.10.1515/jpm.2010.040Search in Google Scholar

[28] Witt A, Berger A, Gruber CJ, Petricevic L, Apfalter P, Worda C, et al. Increased intrauterine frequency of Ureaplasma urealyticum in women with preterm labor and preterm premature rupture of the membranes and subsequent cesarean delivery. Am J Obstet Gynecol. 2005;193:1663–9.10.1016/j.ajog.2005.03.067Search in Google Scholar

[29] Kirchner L, Helmer H, Heinze G, Wald M, Brunbauer M, Weninger M, et al. Amnionitis with Ureaplasma urealyticum or other microbes leads to increased morbidity and prolonged hospitalization in very low birth weight infants. Eur J Obstet Gynecol Reprod Biol. 2007;134:44–50.10.1016/j.ejogrb.2006.09.013Search in Google Scholar

[30] Kundsin RB, Leviton A, Allred EN, Poulin SA. Ureaplasma urealyticum infection of the placenta in pregnancies that ended prematurely. Obstet Gynecol. 1996;87:122–7.10.1016/0029-7844(95)00376-2Search in Google Scholar

[31] Jacobsson B, Mattsby-Baltzer I, Andersch B, Bokstrom H, Holst RM, Wennerholm UB, et al. Microbial invasion and cytokine response in amniotic fluid in a Swedish population of women in preterm labor. Acta Obstet Gynecol Scand. 2003;82:120–8.10.1034/j.1600-0412.2003.00047.xSearch in Google Scholar PubMed

[32] Jacobsson B, Mattsby-Baltzer I, Hagberg H. Interleukin-6 and interleukin-8 in cervical and amniotic fluid: relationship to microbial invasion of the chorioamniotic membranes. Br J Obstet Gynaecol. 2005;112:719–24.10.1111/j.1471-0528.2005.00536.xSearch in Google Scholar PubMed

[33] Jacobsson B, Aaltonen R, Rantakokko-Jalava K, Morken NH, Alanen A. Quantification of Ureaplasma urealyticum DNA in the amniotic fluid from patients in PTL and pPROM and its relation to inflammatory cytokine levels. Acta Obstet Gynecol Scand. 2009;88:63–70.10.1080/00016340802572646Search in Google Scholar

[34] Marconi C, de Andrade Ramos BR, Peracoli JC, Donders GG, da Silva MG. Amniotic fluid interleukin-1 beta and interleukin-6, but not interleukin-8 correlate with microbial invasion of the amniotic cavity in preterm labor. Am J Reprod Immunol. 2011;65:549–56.10.1111/j.1600-0897.2010.00940.xSearch in Google Scholar

[35] Oh KJ, Lee KA, Sohn YK, Park CW, Hong JS, Romero R, et al. Intraamniotic infection with genital mycoplasmas exhibits a more intense inflammatory response than intraamniotic infection with other microorganisms in patients with preterm premature rupture of membranes. Am J Obstet Gynecol. 2010;203:211–8.10.1016/j.ajog.2010.03.035Search in Google Scholar

[36] Hadar A, Ytzhaki O, Shani-Shrem N, Horowitz S, Mazor M, Horowitz S. Amniotic fluid intercellular adhesion molecule-1 is a marker for Ureaplasma infection in women with preterm labor. Am J Obstet Gynecol. 2006;195:1601–6.10.1016/j.ajog.2006.05.020Search in Google Scholar

[37] Doh K, Barton PT, Korneeva I, Perni SC, Bongiovanni AM, Tuttle SL, et al. Differential vaginal expression of interleukin-1 system cytokines in the presence of Mycoplasma hominis and Ureaplasma urealyticum in pregnant women. Infect Dis Obstet Gynecol. 2004;12:79–85.10.1080/10647440400003667Search in Google Scholar

[38] Gauthier DW, Meyer WJ, Bieniarz A. Expectant management of premature rupture of membranes with amniotic fluid cultures positive for Ureaplasma urealyticum alone. Am J Obstet Gynecol. 1994;170:587–90.10.1016/S0002-9378(94)70233-0Search in Google Scholar

[39] Yoon BH, Romero R, Kim M, Kim EC, Kim T, Park JS, et al. Clinical implications of detection of Ureaplasma urealyticum in the amniotic cavity with the polymerase chain reaction. Am J Obstet Gynecol. 2000;183:1130–7.10.1067/mob.2000.109036Search in Google Scholar PubMed

[40] Jones HE, Harris KA, Azizia M, Bank L, Carpenter B, Hartley JC, et al. Differing prevalence and diversity of bacterial species in fetal membranes from very preterm and term labor. PLoS One. 2009;4:e8205.10.1371/journal.pone.0008205Search in Google Scholar PubMed PubMed Central

[41] Payne MS, Feng Z, Li S, Doherty DA, Xu B, Li J, et al. Second trimester amniotic fluid cytokine concentrations, Ureaplasma sp. colonisation status and sexual activity as predictors of preterm birth in Chinese and Australian women. BMC Pregnancy Childbirth. 2014;14:340.10.1186/1471-2393-14-340Search in Google Scholar PubMed PubMed Central

[42] Horowitz S, Mazor M, Horowitz J, Porath A, Glezerman M. Antibodies to Ureaplasma urealyticum in women with intraamniotic infection and adverse pregnancy outcome. Acta Obstet Gynecol Scand. 1995;74:132–6.10.3109/00016349509008922Search in Google Scholar PubMed

[43] Horowitz S, Horowitz J, Mazor M, Porath A, Glezerman M. Ureaplasma urealyticum cervical colonization as a marker for pregnancy complications. Int J Gynaecol Obstet. 1995;48:15–9.10.1016/0020-7292(94)02236-4Search in Google Scholar

[44] Kacerovsky M, Pavlovsky M, Tosner J. Preterm premature rupture of the membranes and genital mycoplasmas. Acta Medica (Hradec Kralove). 2009;52:117–20.10.14712/18059694.2016.115Search in Google Scholar PubMed

[45] Kacerovsky M, Drahosova M, Hornychova H, Pliskova L, Bolehovska R, Forstl M, et al. Value of amniotic fluid interleukin-8 for the prediction of histological chorioamnionitis in preterm premature rupture of membranes. Neuro Endocrinol Lett. 2009;30:733–8.Search in Google Scholar

[46] Kacerovsky M, Pliskova L, Bolehovska R, Musilova I, Hornychova H, Tambor V, et al. The microbial load with genital mycoplasmas correlates with the degree of histologic chorioamnionitis in preterm PROM. Am J Obstet Gynecol. 2011;205:213–7.10.1016/j.ajog.2011.04.028Search in Google Scholar PubMed

[47] Kacerovsky M, Musilova I, Khatibi A, Skogstrand K, Hougaard DM, Tambor V, et al. Intraamniotic inflammatory response to bacteria: analysis of multiple amniotic fluid proteins in women with preterm prelabor rupture of membranes. J Matern Fetal Neonatal Med. 2012;25:2014–9.10.3109/14767058.2012.671873Search in Google Scholar PubMed

[48] Kacerovsky M, Pliskova L, Bolehovska R, Skogstrand K, Hougaard DM, Tsiartas P, et al. The impact of the microbial load of genital mycoplasmas and gestational age on the intensity of intraamniotic inflammation. Am J Obstet Gynecol. 2012;206:342–8.10.1016/j.ajog.2012.01.004Search in Google Scholar PubMed

[49] Kacerovsky M, Pliskova L, Menon R, Kutova R, Musilova I, Maly J, et al. Microbial load of umbilical cord blood Ureaplasma species and Mycoplasma hominis in preterm prelabor rupture of membranes. J Matern Fetal Neonatal Med. 2014;27:1627–32.10.3109/14767058.2014.887068Search in Google Scholar PubMed

[50] Massaro G, Scaravilli G, Simeone S, Capuano S, Pastore E, Forte A, et al. Interleukin-6 and Mycoplasma hominis as markers of preterm birth and related brain damage: our experience. J Matern Fetal Neonatal Med. 2009;22:1063–7.10.1080/14767050903026473Search in Google Scholar

[51] Gonzalez BE, Gene A, Ferrer I, Borras M, Lailla JM. Value of endocervical ureaplasma species colonization as a marker of preterm delivery. Gynecol Obstet Invest. 2006;61:119–23.10.1159/000089457Search in Google Scholar PubMed

[52] Mitsunari M, Yoshida S, Deura I, Horie S, Tsukihara S, Harada T, et al. Cervical Ureaplasma urealyticum colonization might be associated with increased incidence of preterm delivery in pregnant women without prophlogistic microorganisms on routine examination. J Obstet Gynaecol Res. 2005;31:16–21.10.1111/j.1447-0756.2005.00246.xSearch in Google Scholar PubMed

[53] Kafetzis DA, Skevaki CL, Skouteri V, Gavrili S, Peppa K, Kostalos C, et al. Maternal genital colonization with Ureaplasma urealyticum promotes preterm delivery: association of the respiratory colonization of premature infants with chronic lung disease and increased mortality. Clin Infect Dis. 2004;39:1113–22.10.1086/424505Search in Google Scholar PubMed

[54] Carroll SG, Papaioannou S, Ntumazah IL, Philpott-Howard J, Nicolaides KH. Lower genital tract swabs in the prediction of intrauterine infection in preterm prelabour rupture of the membranes. Br J Obstet Gynaecol. 1996;103:54–9.10.1111/j.1471-0528.1996.tb09515.xSearch in Google Scholar

[55] Abele-Horn M, Peters J, Genzel-Boroviczeny O, Wolff C, Zimmermann A, Gottschling W. Vaginal Ureaplasma urealyticum colonization: influence on pregnancy outcome and neonatal morbidity. Infection. 1997;25:286–91.10.1007/BF01720398Search in Google Scholar

[56] Breugelmans M, Vancutsem E, Naessens A, Laubach M, Foulon W. Association of abnormal vaginal flora and Ureaplasma species as risk factors for preterm birth: a cohort study. Acta Obstet Gynecol Scand. 2010;89:256–60.10.3109/00016340903418769Search in Google Scholar

[57] Carey JC, Blackwelder WC, Nugent RP, Matteson MA, Rao AV, Eschenbach DA, et al. Antepartum cultures for Ureaplasma urealyticum are not useful in predicting pregnancy outcome. The Vaginal Infections and Prematurity Study Group. Am J Obstet Gynecol. 1991;164:728–33.10.1016/0002-9378(91)90505-LSearch in Google Scholar

[58] Martinez MA, Ovalle A, Santa-Cruz A, Barrera B, Vidal R, Aguirre R. Occurrence and antimicrobial susceptibility of Ureaplasma parvum (Ureaplasma urealyticum biovar 1) and Ureaplasma urealyticum (Ureaplasma urealyticum biovar 2) from patients with adverse pregnancy outcomes and normal pregnant women. Scand J Infect Dis. 2001;33:604–10.10.1080/00365540110026782Search in Google Scholar PubMed

[59] Kong F, Ma Z, James G, Gordon S, Gilbert GL. Species identification and subtyping of Ureaplasma parvum and Ureaplasma urealyticum using PCR-based assays. J Clin Microbiol. 2000;38:1175–9.10.1128/JCM.38.3.1175-1179.2000Search in Google Scholar PubMed PubMed Central

[60] Kemp MW, Saito M, Kallapur SG, Jobe AH, Keelan JA, Li S, et al. Inflammation of the fetal ovine skin following in utero exposure to Ureaplasma parvum. Reprod Sci. 2011;18:1128–37.10.1177/1933719111408114Search in Google Scholar PubMed PubMed Central

[61] Moss TJ, Nitsos I, Ikegami M, Jobe AH, Newnham JP. Experimental intrauterine Ureaplasma infection in sheep. Am J Obstet Gynecol. 2005;192:1179–86.10.1016/j.ajog.2004.11.063Search in Google Scholar PubMed

[62] Novy MJ, Duffy L, Axthelm MK, Sadowsky DW, Witkin SS, Gravett MG, et al. Ureaplasma parvum or Mycoplasma hominis as sole pathogens cause chorioamnionitis, preterm delivery, and fetal pneumonia in rhesus macaques. Reprod Sci. 2009;16:56–70.10.1177/1933719108325508Search in Google Scholar PubMed

[63] Allen-Daniels MJ, Serrano MG, Pflugner LP, Fettweis JM, Prestosa MA, Koparde VN, et al. Identification of a gene in Mycoplasma hominis associated with preterm birth and microbial burden in intraamniotic infection. Am J Obstet Gynecol. 2015;212:779.10.1016/j.ajog.2015.01.032Search in Google Scholar PubMed PubMed Central

[64] Abrahams VM, Potter JA, Bhat G, Peltier MR, Saade G, Menon R. Bacterial modulation of human fetal membrane Toll-like receptor expression. Am J Reprod Immunol. 2013;69:33–40.10.1111/aji.12016Search in Google Scholar PubMed PubMed Central

[65] Nguyen DP, Gerber S, Hohlfeld P, Sandrine G, Witkin SS. Mycoplasma hominis in mid-trimester amniotic fluid: relation to pregnancy outcome. J Perinat Med. 2004;32:323–6.10.1515/JPM.2004.060Search in Google Scholar PubMed

[66] Hillier SL, Nugent RP, Eschenbach DA, Krohn MA, Gibbs RS, Martin DH, et al. Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The Vaginal Infections and Prematurity Study Group. N Engl J Med. 1995;333:1737–42.10.1056/NEJM199512283332604Search in Google Scholar PubMed

[67] Agger WA, Siddiqui D, Lovrich SD, Callister SM, Borgert AJ, Merkitch KW, et al. Epidemiologic factors and urogenital infections associated with preterm birth in a midwestern U.S. population. Obstet Gynecol. 2014;124:969–77.10.1097/AOG.0000000000000470Search in Google Scholar PubMed PubMed Central

[68] Donders GG, Van BB, Caudron J, Londers L, Vereecken A, Spitz B. Relationship of bacterial vaginosis and mycoplasmas to the risk of spontaneous abortion. Am J Obstet Gynecol. 2000;183:431–7.10.1067/mob.2000.105738Search in Google Scholar PubMed

[69] Leli C, Meucci M, Vento S, D’Alo F, Farinelli S, Perito S, et al. Microbial and vaginal determinants influencing Mycoplasma hominis and Ureaplasma urealyticum genital colonization in a population of female patients. Infez Med. 2013;21:201–6.Search in Google Scholar

[70] Kwak DW, Hwang HS, Kwon JY, Park YW, Kim YH. Co-infection with vaginal Ureaplasma urealyticum and Mycoplasma hominis increases adverse pregnancy outcomes in patients with preterm labor or preterm premature rupture of membranes. J Matern Fetal Neonatal Med. 2014;27:333–7.10.3109/14767058.2013.818124Search in Google Scholar PubMed

[71] Capoccia R, Greub G, Baud D. Ureaplasma urealyticum, Mycoplasma hominis and adverse pregnancy outcomes. Curr Opin Infect Dis. 2013;26:231–40.10.1097/QCO.0b013e328360db58Search in Google Scholar PubMed

[72] Odendaal HJ, Popov I, Schoeman J, Grove D. Preterm labour–is Mycoplasma hominis involved? S Afr Med J. 2002;92:235–7.Search in Google Scholar

[73] Menard JP, Mazouni C, Salem-Cherif I, Fenollar F, Raoult D, Boubli L, et al. High vaginal concentrations of Atopobium vaginae and Gardnerella vaginalis in women undergoing preterm labor. Obstet Gynecol. 2010;115:134–40.10.1097/AOG.0b013e3181c391d7Search in Google Scholar PubMed

[74] Edwards RK, Ferguson RJ, Reyes L, Brown M, Theriaque DW, Duff P. Assessing the relationship between preterm delivery and various microorganisms recovered from the lower genital tract. J Matern Fetal Neonatal Med. 2006;19:357–63.10.1080/00207170600712071Search in Google Scholar PubMed

[75] Lu GC, Schwebke JR, Duffy LB, Cassell GH, Hauth JC, Andrews WW, et al. Midtrimester vaginal Mycoplasma genitalium in women with subsequent spontaneous preterm birth. Am J Obstet Gynecol. 2001;185:163–5.10.1067/mob.2001.115113Search in Google Scholar PubMed

[76] Lis R, Rowhani-Rahbar A, Manhart LE. Mycoplasma genitalium infection and female reproductive tract disease: a meta-analysis. Clin Infect Dis. 2015;61:418–26.10.1093/cid/civ312Search in Google Scholar

[77] Short VL, Jensen JS, Nelson DB, Murray PJ, Ness RB, Haggerty CL. Mycoplasma genitalium among young, urban pregnant women. Infect Dis Obstet Gynecol. 2010;2010:984760.10.1155/2010/984760Search in Google Scholar

[78] Hitti J, Garcia P, Totten P, Paul K, Astete S, Holmes KK. Correlates of cervical Mycoplasma genitalium and risk of preterm birth among Peruvian women. Sex Transm Dis. 2010;37:81–5.10.1097/OLQ.0b013e3181bf5441Search in Google Scholar

[79] Cultrera R, Seraceni S, Germani R, Contini C. Molecular evidence of Ureaplasma urealyticum and Ureaplasma parvum colonization in preterm infants during respiratory distress syndrome. BMC Infect Dis. 2006;6:166.10.1186/1471-2334-6-166Search in Google Scholar

[80] Viscardi RM, Hashmi N, Gross GW, Sun CC, Rodriguez A, Fairchild KD. Incidence of invasive ureaplasma in VLBW infants: relationship to severe intraventricular hemorrhage. J Perinatol. 2008;28:759–65.10.1038/jp.2008.98Search in Google Scholar

[81] Goldenberg RL, Andrews WW, Goepfert AR, Faye-Petersen O, Cliver SP, Carlo WA, et al. The Alabama Preterm Birth Study: umbilical cord blood Ureaplasma urealyticum and Mycoplasma hominis cultures in very preterm newborn infants. Am J Obstet Gynecol. 2008;198:43–5.10.1016/j.ajog.2007.07.033Search in Google Scholar

[82] Hahn HS, Lee KH, Koo YJ, Kim SG, Rhee JE, Kim MY, et al. Distribution and perinatal transmission of bacterial vaginal infections in pregnant women without vaginal symptoms. Scand J Infect Dis. 2014;46:348–53.10.3109/00365548.2014.880183Search in Google Scholar

[83] Rosenstein IJ, Morgan DJ, Lamont RF, Sheehan M, Dore CJ, Hay PE, et al. Effect of intravaginal clindamycin cream on pregnancy outcome and on abnormal vaginal microbial flora of pregnant women. Infect Dis Obstet Gynecol. 2000;8:158–65.10.1002/1098-0997(2000)8:3/4<158::AID-IDOG11>3.0.CO;2-VSearch in Google Scholar

[84] De Francesco MA, Caracciolo S, Bonfanti C, Manca N. Incidence and antibiotic susceptibility of Mycoplasma hominis and Ureaplasma urealyticum isolated in Brescia, Italy, over 7 years. J Infect Chemother. 2013;19:621–7.10.1007/s10156-012-0527-zSearch in Google Scholar

[85] Ramsey PS, Vaules MB, Vasdev GM, Andrews WW, Ramin KD. Maternal and transplacental pharmacokinetics of azithromycin. Am J Obstet Gynecol. 2003;188:714–8.10.1067/mob.2003.141Search in Google Scholar

[86] Sutton AL, Acosta EP, Larson KB, Kerstner-Wood CD, Tita AT, Biggio JR. Perinatal pharmacokinetics of azithromycin for cesarean prophylaxis. Am J Obstet Gynecol. 2015;212:812–6.10.1016/j.ajog.2015.01.015Search in Google Scholar

[87] Merchan LM, Hassan HE, Terrin ML, Waites KB, Kaufman DA, Ambalavanan N, et al. Pharmacokinetics, microbial response, and pulmonary outcomes of multidose intravenous azithromycin in preterm infants at risk for Ureaplasma respiratory colonization. Antimicrob Agents Chemother. 2015;59:570–8.10.1128/AAC.03951-14Search in Google Scholar

[88] Furfaro LL, Spiller OB, Keelan JA, Payne MS. In vitro activity of solithromycin and its metabolites, CEM-214 and N-acetyl-CEM-101, against 100 clinical Ureaplasma spp. isolates compared with azithromycin. Int J Antimicrob Agents. 2015;46:319–24.10.1016/j.ijantimicag.2015.04.015Search in Google Scholar

[89] Manhart LE, Broad JM, Golden MR. Mycoplasma genitalium: should we treat and how? Clin Infect Dis. 2011;53 Suppl 3:S129–42.10.1093/cid/cir702Search in Google Scholar

[90] Mazor M, Horowitz S, Meril T, Bar-Am I. Eradication of Ureaplasma urealyticum from amniotic fluid. Isr J Med Sci. 1992;28:296–8.Search in Google Scholar

[91] Romero R, Hagay Z, Nores J, Sepulveda W, Mazor M. Eradication of Ureaplasma urealyticum from the amniotic fluid with transplacental antibiotic treatment. Am J Obstet Gynecol. 1992;166:618–20.10.1016/0002-9378(92)91686-5Search in Google Scholar

[92] Smorgick N, Frenkel E, Zaidenstein R, Lazarovitch T, Sherman DJ. Antibiotic treatment of intra-amniotic infection with Ureaplasma urealyticum. A case report and literature review. Fetal Diagn Ther. 2007;22:90–3.10.1159/000097103Search in Google Scholar PubMed

[93] Berg TG, Philpot KL, Welsh MS, Sanger WG, Smith CV. Ureaplasma/Mycoplasma-infected amniotic fluid: pregnancy outcome in treated and nontreated patients. J Perinatol. 1999;19:275–7.10.1038/sj.jp.7200185Search in Google Scholar PubMed

[94] Grigsby PL, Novy MJ, Sadowsky DW, Morgan TK, Long M, Acosta E, et al. Maternal azithromycin therapy for Ureaplasma intraamniotic infection delays preterm delivery and reduces fetal lung injury in a primate model. Am J Obstet Gynecol. 2012;207:475.10.1016/j.ajog.2012.10.871Search in Google Scholar PubMed PubMed Central

[95] Ogasawara KK, Goodwin TM. Efficacy of azithromycin in reducing lower genital Ureaplasma urealyticum colonization in women at risk for preterm delivery. J Matern Fetal Med. 1999;8:12–6.10.3109/14767059909063146Search in Google Scholar

[96] Witt A, Sommer EM, Cichna M, Postlbauer K, Widhalm A, Gregor H, et al. Placental passage of clarithromycin surpasses other macrolide antibiotics. Am J Obstet Gynecol. 2003;188:816–9.10.1067/mob.2003.171Search in Google Scholar PubMed

[97] Azizmohammadi S, Azizmohammadi S. Antimicrobial Susceptibility Patterns of Ureaplasma urealyticum and Mycoplasma hominis Isolated From Pregnant Women. Iran Red Crescent Med J. 2015;17:e17211.10.5812/ircmj.17211Search in Google Scholar

[98] Gomez R, Romero R, Nien JK, Medina L, Carstens M, Kim YM, et al. Antibiotic administration to patients with preterm premature rupture of membranes does not eradicate intra-amniotic infection. J Matern Fetal Neonatal Med. 2007;20:167–73.10.1080/14767050601135485Search in Google Scholar

[99] McCormack WM, Rosner B, Lee YH, Munoz A, Charles D, Kass EH. Effect on birth weight of erythromycin treatment of pregnant women. Obstet Gynecol. 1987;69:202–7.10.1016/0020-7292(87)90105-6Search in Google Scholar

[100] Eschenbach DA, Nugent RP, Rao AV, Cotch MF, Gibbs RS, Lipscomb KA, et al. A randomized placebo-controlled trial of erythromycin for the treatment of Ureaplasma urealyticum to prevent premature delivery. The Vaginal Infections and Prematurity Study Group. Am J Obstet Gynecol. 1991;164:734–42.10.1016/0002-9378(91)90506-MSearch in Google Scholar

[101] Ozdemir R, Erdeve O, Dizdar EA, Oguz SS, Uras N, Saygan S, et al. Clarithromycin in preventing bronchopulmonary dysplasia in Ureaplasma urealyticum-positive preterm infants. Pediatrics. 2011;128:e1496–501.10.1542/peds.2011-1350Search in Google Scholar PubMed

[102] Ozdemir R, Sari FN, Tunay ZO, Erdeve O, Canpolat FE, Oguz SS, et al. The association between respiratory tract Ureaplasma urealyticum colonization and severe retinopathy of prematurity in preterm infants </=1250 g. Eye (Lond). 2012;26:992–6.10.1038/eye.2012.77Search in Google Scholar PubMed PubMed Central

[103] Ogasawara KK, Goodwin TM. The efficacy of prophylactic erythromycin in preventing vertical transmission of Ureaplasma urealyticum. Am J Perinatol. 1997;14:233–7.10.1055/s-2007-994133Search in Google Scholar PubMed